Skip to main content

Aeterna Zentaris Inc(AEZS-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Aeterna Zentaris Inc up on Thursday (AEZS)

Automated Summaries - The Globe and Mail - Fri Mar 29, 4:02PM CDT

Today during trading, Aeterna Zentaris Inc shares closed at $2.91 after opening the day at $3.01. Intraday prices ranged from a low of $2.80 to a high of $3.01.

Share prices gained 2.83 percent from the previous day's close of $2.83.

During the day across North America, the TSX Composite closed 0.27% at 22167.03, the S&P 500 closed 0.11% at 5254.35, the Dow Jones Industrial Average closed 0.12% at 39807.37 and the Nasdaq Composite closed -0.12% at 16379.46.

Aeterna Zentaris Inc traded under AEZS on the Toronto Stock Exchange (TSX).

A total of 2,920 shares was traded during the session, with total trades of 18, while having an average volume of 1,553 over 5 days.

The TSX market on the whole today saw 3,290 price advancers against 1,913 declines and 170 unchanged.

During the prior 52 weeks, AEZS.TO has traded as high as $4.48 (April 25,2023) and low as $1.91 (November 01,2023). Moreover, the shares have decreased -20.71% in 52 weeks, while they have boosted 13.23% this year.

It announced a 1237.50 dividend on July 22/99, with an August 11/99 ex-date and January 01/70 pay day.

Following today's trading, Aeterna Zentaris Inc has a market capitalization of $13.74 million on a float of 4,856 shares outstanding. Its annual EPS is $-4.81.

Aeterna Zentaris Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Aeterna Zentaris Inc's consensus rating is "Strong Buy" based on 1 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe